Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
4
Filing Date
5/12/2026
Updated
5/13/26, 2:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership